DXC Technology has reached a definitive agreement to sell its healthcare software provider business to privately held Dedalus Group for $525 million in cash.

“The sale of our healthcare provider software business to Dedalus is consistent with our strategy of focusing on the Enterprise Technology Stack and rationalizing our portfolio. The transaction promises to be beneficial to all our key stakeholders, including our customers and our people,” said Mike Salvino, president and chief executive officer, DXC Technology. 

“The addition of DXC’s healthcare software business will accelerate our growth initiatives that started three years ago and benefit the more than 3 million healthcare professionals who use our technology to treat more than 200 million patients every year,” said Giorgio Moretti, executive chairman of the Dedalus Group.

The agreement brings together DXC’s software business for healthcare providers with Dedalus, a leading European healthcare and diagnostic software company, to create an even stronger global force in the clinical IT areas of hospital information systems (HIS), primary and social care, integrated care and diagnostics. The resulting business will be uniquely positioned to accelerate the digital transformation of clinical activity and consequently the effectiveness of healthcare systems.

DXC’s innovations include an open digital health platform that it says helps improve care outcomes by delivering contextual and actionable insights across the healthcare ecosystem. 

The transaction was approved by DXC’s Board of Directors and is expected to close by March 2021, subject to the satisfaction of customary closing conditions and the receipt of certain third-party consents and regulatory approvals. The sale is not subject to any financing conditions or shareholder approvals.

Previous post

Startmate announces partners for women-focused Fellowship program

Next post

Index Exchange First Exchange To Expand LiveRamp IdentityLink Globally